logo
#

Latest news with #Diamantas

FDA plans to review chemicals in US food supply, official says
FDA plans to review chemicals in US food supply, official says

Yahoo

time15-05-2025

  • Health
  • Yahoo

FDA plans to review chemicals in US food supply, official says

By Tom Polansek ROSEMONT, Illinois (Reuters) - The U.S. Food and Drug Administration plans to step up safety reviews on chemicals in foods, including one widely used as a preservative in products containing fats, said Kyle Diamantas, the agency's top food official, on Thursday. Health Secretary Robert F. Kennedy Jr., whose agency oversees the FDA, has pledged to tackle chronic illnesses by overhauling the U.S. diet. He has pushed for bans on synthetic food colors and encouraged fast-food chains to switch to beef tallow instead of seed oils for French fries. The FDA, which has suffered mass layoffs under President Donald Trump, will update a list of chemicals that will be top priorities for reviews, said Diamantas, acting deputy commissioner for human foods. "Historically FDA has been somewhat reactionary when it comes to reviewing chemicals in the food supply," he said at a food safety conference outside Chicago. "The goal is to move to a proactive process to ensure that the chemicals in our food remain safe." The FDA will prioritize reviews of chemicals including butylated hydroxytoluene (BHT); butylated hydroxyanisole (BHA); and azodicarbonamide (ADA), Diamantas said. BHT is one of the most commonly used antioxidants in foods containing fats, according to the health department. The FDA plans to release a scheme for highlighting other chemicals for reviews that will be available for public feedback this month, Diamantas said. Chemicals may be assessed based on consumers' concerns or on other countries' data and regulatory actions, he said. Even as food chemicals and nutrition have received a lot of attention, Diamantas told the conference that the FDA is still committed to microbiological food safety, which is the agency's division with the most employees and funding. Kennedy said on Wednesday that the "central focus" of the FDA and National Institutes of Health will be on studying ultra-processed foods, sugars and food additives. At the CDC, which also operates under Kennedy, an environmental health division endured layoffs and is no longer at the agency, said Megin Nichols, director of CDC's division of foodborne, waterborne, and environmental diseases. The division was critical to food safety and CDC continues to "maintain the spirit of that work," Nichols said in a virtual appearance at the conference.

He Fought Claims of Harm From Infant Formula. Now He Regulates It.
He Fought Claims of Harm From Infant Formula. Now He Regulates It.

New York Times

time04-03-2025

  • Business
  • New York Times

He Fought Claims of Harm From Infant Formula. Now He Regulates It.

The new head of the Food and Drug Administration division that regulates infant formula was in recent months a corporate lawyer defending a top formula maker from claims that its product gave rise to debilitating harm to premature babies. Kyle A. Diamantas joined the F.D.A. last month to lead the food division, leaving the law firm Jones Day, which has served as a pipeline of talent to both Trump administrations. As a partner in Jones Day's Miami office, Mr. Diamantas's recent work included defending Abbott Laboratories in lawsuits accusing the company of failing to adequately warn parents that its specialized formula for premature infants was associated with an elevated risk of a deadly bowel condition. Abbott lost the case and was ordered to pay $495 million. Abbott is appealing the verdict. Mr. Diamantas's role in the Abbott cases has not been previously reported. The leader of the F.D.A.'s food division has a wide-ranging role in ensuring the safety of about 80 percent of the food supply in the United States. In that job, Mr. Diamantas is also expected to take a lead role in enacting Health Secretary Robert F. Kennedy Jr.'s agenda, which calls for reducing additives in food and eliminating what Mr. Kennedy has described as corruption in public health agencies. 'We will shut the revolving door to re-establish public trust,' Mr. Kennedy told the Health and Human Services Department's staff during his first week in office. The selection of Mr. Diamantas to run the food division struck Representative Rosa DeLauro, who has worked on infant formula issues, as a 'betrayal.' She has focused on infant formula since 2022, when a major formula shortage began after Abbott temporarily shut down its Michigan formula plant amid findings of unsanitary conditions. 'The F.D.A.'s job is to protect our babies, not the corporations that poisoned them,' Ms. DeLauro, a Connecticut Democrat, said in a statement emailed to The New York Times. 'Appointing an Abbott lawyer to oversee food safety, which includes infant formula, is letting the fox guard the henhouse.' Mr. Diamantas did not respond to a request for comment. The F.D.A. said he will comply with his routine ethics agreement with the agency, which includes pledges to recuse himself from specific matters related to Abbott and also British American Tobacco, another prominent Jones Day client. Health and Human Services officials declined to make Mr. Diamantas's ethics agreement available to the Times. 'Mr. Diamantas shares Secretary Kennedy's vision of improving nutritional outcomes, ensuring the food supply is safe and healthy, and continuing to carry out the F.D.A.'s overall mission of protecting and promoting public health,' a spokesman for the department of Health and Human Services, Andrew Nixon, said. The F.D.A. did not issue a formal announcement about Mr. Diamantas' role, but on Feb. 24, the agency put up a web page listing him as the acting deputy commissioner of human foods and calling him its 'top food executive.' He will also will represent the agency in dealings with foreign governments and the White House. Before he joined Jones Day in 2021, Mr. Diamantas (who has also been shown hunting with Donald Trump Jr., the president's son, in a photo on social media) worked at another law firm. There, he defended a cannabis company called Hemp Bombs against claims about its CBD products, which are derived from the cannabis plant. He also defended Whole Foods Markets in a lawsuit claiming that it sold a CBD product that misled users to believe it would reduce pain. The F.D.A. has taken the position that CBD is unsafe to add to the food supply and has gone after companies in situations it deemed high risk. The agency began an effort to determine how it would regulate CBD but in early 2023 concluded that Congress needed to step in. The deadly bowel condition associated with infant formula for preterm infants has also been debated at the F.D.A. Hundreds of lawsuits are pending, many claiming that Abbott failed to warn parents of the outsized risk of infection that arises when very low-weight babies — around 3 ½ pounds or less — are fed formula instead of breast milk. In three infant formula cases filed in a Missouri court, Mr. Diamantas was admitted to represent Abbott in March 2024, court records show. In two of the cases, his role was described in court records as representing two Abbott sales representatives. He did not address the jury during the high-profile trial of Margo Gill v. Abbott, which ended with the jury levying $95 million in compensatory and $400 million in punitive damages against the company. The case centered around whether Abbott had adequately warned Ms. Gill that very low-weight babies who are fed infant formula face an elevated risk of a bowel condition called necrotizing enterocolitis, or NEC, which can quickly lead to destruction of the intestines and death. At six weeks old, Ms. Gill's daughter developed NEC about 24 hours after she was fed formula. She left the neonatal intensive care unit, or NICU, with extensive bowel and brain damage, according to court testimony viewed on Courtroom View Network. Ms. Gill testified during the trial that at 3, her daughter was unable to talk, walk or eat without a feeding tube. Abbott did not argue that Ms. Gill had been warned, rather saying it was the doctor's role to counsel families. During the trial in July, a lawyer for Ms. Gill, Jake Plattenberger, showed jurors internal Abbott documents saying that infant formula 'is thought to be a contributing factor to the development of NEC.' He also told the jury that about 90 percent of the preterm infants who got the condition had been fed formula. He showed a study of 1,800 preterm infants that concluded that formula feeding raises the risk of developing NEC by 180 percent. James F. Hurst, the lead trial lawyer for Abbott, argued that formula does not cause the condition. The product is typically used in hospitals and is labeled 'for institutional use only' and 'use as directed by a doctor.' On a slide presented to the jury, Mr. Hurst wrote: 'Different Words On Abbott's Label (Or Anywhere Else) Wouldn't Have Changed Anything' for the infant. He also argued that the cascade of injuries Ms. Gill's daughter sustained, including brain damage, were related to other factors, including her birth complications and very low oxygen level. 'These premature infant formulas and human milk fortifiers are part of the standard of care for premature infants and have been used safely for 45 years, nourishing generations of NICU babies,' Abbott said in a statement on Monday. On July 26, jurors sided with Ms. Gill and awarded nearly half a billion to her family. Soon after, Abbott's chief executive, Robert B. Ford, publicly warned that the company might need to stop selling some formula for preterm infants. Mr. Ford turned to the F.D.A. three days after the verdict, records show, and met with Dr. Robert Califf, the F.D.A. commissioner, and others in the food division. Soon, officials with the F.D.A. and two other health agencies began to work quickly on a consensus statement about NEC. A person familiar with the process, who requested anonymity to discuss the dialogue, said formula companies had asked government officials to craft a consensus statement, but did not dictate what it said. Some working group members had relationships with Abbott, such as through accepting speaker fees, that were not specifically outlined in the final report, records show. On Oct. 3, the health department released its conclusion: '1) There is no conclusive evidence that preterm infant formula causes NEC; and 2) there is strong evidence that human milk is protective against NEC.' The statement echoes Abbott's position in court and is expected to help formula makers in upcoming cases. Since the Gill verdict, another similar case ended in a $60 million verdict in favor of a family and another case resulted in a victory for formula makers. The F.D.A.'s food division handles myriad other matters in its role regulating the majority of the food supply. On infant formula, the division is trying to hold Abbott and other companies to a high standard after inspectors at Abbott's Michigan plant discovered a leaking roof, pooled water and evidence of a deadly bacteria. The plant was shut down for an overhaul, setting off a monthslong infant formula shortage in 2022 that left parents scrambling. The food division also leads investigations into food-borne illnesses, working with states and other federal officials to use high-tech tools to connect sick patients to contamination at food plants or vegetable farms. The division has also been rolling out rules making it easier to trace food through the supply chain and helping farmers ensure irrigation water does not spread bacteria on crops. Mr. Kennedy has outlined other priorities for the agency, including to scrutinize chemical additives in food. At least one influential supporter of Mr. Kennedy sees Mr. Diamantas's experience as an asset. During the weekend of the inauguration, Vani Hari, a clean-food activist known online as the Food Babe, said she met and chatted with Mr. Diamantas at three different events. The first time, his wife leaned in and told Ms. Hari she had been a follower of her blog for years. 'He is all on board to change the way the regulatory system works,' Ms. Hari said. Rather than see his work with Abbott and other corporations as a potential conflict of interest, Ms. Hari said it gave him insight into how to work with them. 'It's just the way the world works. The companies will have to be involved in these discussions,' Ms. Hari said. 'He's very passionate about the Make America Healthy Again movement but he's also very levelheaded. He'll figure out a solution that is feasible to everyone to change our food system.'

Trump tasks son's hunting pal with keeping the US food supply safe
Trump tasks son's hunting pal with keeping the US food supply safe

Yahoo

time25-02-2025

  • Business
  • Yahoo

Trump tasks son's hunting pal with keeping the US food supply safe

The acting federal government official overseeing the vast majority of the US's food supply is a Florida attorney who reportedly is a hunting buddy of Donald Trump Jr, the president's eldest child and namesake. As Vanity Fair reported, acting deputy commissioner for human foods at the Food and Drug Administration Kyle Diamantas will be responsible for overseeing all FDA activities related to nutrition and food safety for the elder Donald Trump's second presidential administration. The FDA's website says the 37-year-old's role has authority over all entities and operations within the Human Foods Program. Duties include resource allocation, risk prioritization strategies, decision-making, policy initiatives and major response activities concerning human foods. Diamantas will also oversee food resources in the agency's office of inspections and investigations in a post that does not require Senate approval. And, as reported by Vanity Fair on Monday, Diamantas will oversee approximately 80% of the country's food supply. In reporting on his friendship with the president's son, Vanity Fair pointed to a photograph of Trump Jr and Diamantas together in 2021, grinning while holding dead wild turkeys. Diamantas holds a juris doctorate from the University of Florida's Levin College of Law and a bachelor's in pre-law political science from the University of Central Florida. In 2024, he became a partner at Jones Day law firm in Miami, having joined the firm three years earlier, according to his LinkedIn page. Vanity Fair asserted it was unclear 'what skills … Diamantas will bring' to his role in Trump's administration. But Food Safety Magazine reported that Diamantas has authored several articles on food regulatory topics. And in his now-archived Jones Day biography reported by Vanity Fair, he is described as having 'more than 10 years of experience advising food, cosmetic, dietary supplement, drug, and other life sciences and consumer goods clients on a wide range of regulatory, compliance, and enforcement matters'. The FDA's website states that Diamantas has 'extensive experience' working with various federal and state agencies and policymakers, scientific organizations, consumer advocacy groups and industry stakeholders. The website also claims he has 'wide-ranging experience on matters spanning regulatory, compliance, investigative, enforcement, rule making and legislation'. Bloomberg recently reported that Diamantas in November was part of a team that wrote about a new post-market safety assessment group established by the FDA to review chemicals in food. Diamantas's appointment comes as the FDA grapples with investigating an outbreak of Listeria monocytogenes infections linked to frozen supplemental shakes. The outbreak had resulted in 12 reported deaths as of Monday. The former head of the FDA's food division, Jim Jones, resigned on 17 February after the Trump administration laid off 89 staffers in that division. Jones described the layoffs as 'indiscriminate'. In his resignation letter, obtained by Bloomberg, Jones reportedly expressed that he was 'looking forward to working to pursue the department's agenda of improving the health of Americans by reducing diet-related chronic disease and risks from chemicals in food'. However, he felt that due to the new administration's 'disdain for the very people' needed to make these changes, it would be 'fruitless for me to continue in this role'.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store